Lv3
328 积分 2024-09-02 加入
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
1个月前
已完结
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
1个月前
已完结
Class III β-tubulin in normal and cancer tissues
3个月前
已完结
Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study
3个月前
已完结
PEG10 Is a c-MYC Target Gene in Cancer Cells
3个月前
已完结
Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells
3个月前
已完结
Antrodia camphorata extract (ACE)-induced apoptosis is associated with BMP4 expression and p53-dependent ROS generation in human colon cancer cells
3个月前
已完结
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial
3个月前
已完结
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
3个月前
已完结
Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer
6个月前
已完结
皖公网安备34019202002308
